Avaleht/Aktsiad/TLSI

TLSI

USD

TriSalus Life Sciences Inc. Common Stock

$4.390+0.010 (0.228%)

Reaalajas hind

Healthcare

Meditsiiniseadmed

Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Turunäitajad

Avatud

$4.380

Kõrge

$4.410

Madal

$4.277

Maht

0.10M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

218.9M

Tööstusharu

Meditsiiniseadmed

Riik

United States

Kauplemisstatistika

Keskmine maht

0.12M

Börs

NGM

Valuuta

USD

52 nädala vahemik

Madal $3.42Praegune $4.390Kõrge $5.88

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 26. okt 2025

Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

TLSI (TriSalus Life Sciences): Unlocking Value in Oncology Tech

Key Insights at a Glance

Upside Catalysts: AI models project 1.1%-2.8% gains over 3 days, aligning with recent technical signals near key support.
Fundamental Edge: P/E ratio (-4.3x) beats industry average (-6.5x), while revenue growth (52%) outpaces peers.
Risk Factors: Low volatility (beta <1) paired with thin trading volume may limit liquidity; 3/5 risk rating.
Strategic Play: $5.12 support zone matches entry targets, but stop-loss at $4.60 guards against sudden swings.

Technical Signals: Mixed Momentum, Clear Support

Bearish DMI: ADX at 11.7 confirms weak trend strength (-DI 14.8 vs. +DI 14.0).
OBV Surge: Volume spiked 1.6x average on October 23, hinting of accumulation.
MACD Warning: Death cross (MACD 0.0052 < signal 0.0127) signals short-term weakness.
Bollinger Band Breakthrough: Price hovers near $5.12 support, a level not breached since October 17.

Trade Setup: Watch for a

Seotud uudised

28. aug 2025 · 12:00

BusinessWire

TriSalus Life Sciences to Participate in Upcoming September Investor Conferences

TriSalus Life Sciences® Inc. (NASDAQ:TLSI) ("TriSalus" or the "Company"), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid

Vaata rohkem